Giles EM, D’Adamo GL, Forster SC. The future of faecal transplants. Nat Rev Microbiol. 2019;17(12):719. doi: 10.1038/s41579-019-0271-9 Yelin I, Flett KB, Merakou C, et al. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019;25(11):1728-1732. doi: 10.1038/s41591-019-0626-9 Ullah H, Arbab S, Chang C, et al. Gut microbiota therapy in gastrointestinal diseases. Front Cell Dev Biol. 2025;13:1514636. doi: 10.3389/fcell.2025.1514636 Klyachko NL, Arzt CJ, Li SM, Gololobova OA, Batrakova EV. Extracellular vesicle-based therapeutics: Preclinical and clinical investigations. Pharmaceutics. 2020;12(12):1171. doi: 10.3390/pharmaceutics12121171 Xie J, Li Q, Nie S. Bacterial extracellular vesicles: An emerging postbiotic. Trends Food Sci Technol. 2024;143:104275. doi: 10.1016/j.tifs.2023.104275 Zhou X, Li W, Wang S, et al. YAP aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis. Cell Rep. 2019;27(4):1176-1189.e5. doi: 10.1016/j.celrep.2019.03.028 He T, Ma J, Liu S, et al. MicroRNA‐microbiota interactions: Emerging strategies for modulating intestinal homeostasis and enhancing host health. IMetaomics. 2025;2(1):e57. doi: 10.1002/imo2.57 Shen Q, Huang Z, Ma L, et al. Extracellular vesicle miRNAs promote the intestinal microenvironment by interacting with microbes in colitis. Gut Microbes. 2022;14(1):2128604. doi: 10.1080/19490976.2022.2128604 Wan S, Wang K, Huang P, et al. Mechanoelectronic stimulation of autologous extracellular vesicle biosynthesis implant for gut microbiota modulation. Nat Commun. 2024;15(1):3343. doi: 10.1038/s41467-024-47710-w Zhou J, Li M, Chen Q, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13(1):3432. doi: 10.1038/s41467-022-31171-0 Zeng Y, Cui X, Li H, Wang Y, Cheng M, Zhang X. Extracellular vesicles originating from the mechanical microenvironment in the pathogenesis and applications for cardiovascular diseases. Regen Ther. 2024;26:1069-1077. doi: 10.1016/j.reth.2024.10.012 Patel N, Avery E, Chung EJ. Supramolecular hydrogels for sustained extracellular vesicle delivery. MRS Commun. 2024;14(5):1037-1044. doi: 10.1557/s43579-024-00589-6 Wang Y, Meng D, Shi X, et al. Injectable hydrogel with miR- 222-engineered extracellular vesicles ameliorates myocardial ischemic reperfusion injury via mechanotransduction. Cell Rep Med. 2025;6(3):101987. doi: 10.1016/j.xcrm.2025.101987 Meng F, Deng Y, Li W, Zheng A, Lu M, Xing H. Engineered extracellular vesicles: From design strategies to therapeutic applications.Extracell Vesicle. 2026;7:100104. doi: 10.1016/j.vesic.2026.100104 Chrzanowski W, Wolfram J. Rethinking extracellular vesicle signaling. Adv Mater. 2026;38(20):e22172. doi: 10.1002/adma.202522172 Kojima R, Bojar D, Rizzi G, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat Commun. 2018;9(1):1305. doi: 10.1038/s41467-018-03733-8 Rudge C, McClelland R, Chrzanowski W, Davis RL. The regulatory landscape for extracellular vesicle therapies: Australian context and future directions. Extracell Vesicles Circ Nucl Acids. 2026;7(1):292-301. doi: 10.20517/evcna.2025.129